# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-038560
Filing Date
2023-10-27
Accepted
2023-10-27 17:23:48
Documents
3
Period of Report
2023-10-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm | PRE 14A | 221400
2 |  | proxy_001.jpg | GRAPHIC | 840792
3 |  | proxy_002.jpg | GRAPHIC | 739283
| Complete submission text file | 0001493152-23-038560.txt |  | 2398663

Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40023 | Film No.: 231356448
SIC: 2834 Pharmaceutical Preparations